Introduction
Clostridium novyi causes gangrene in humans and animals. Among the various toxins produced by this pathogen (Hatheway, 1990) , alpha toxin has a molecular weight of approximately 200-250 kDa and enzymatic activity on Rho receptors in mammalian cells, which cause vascular permeability and cell rounding in culture (Bette et al., 1991) . Homology studies have shown that alpha toxin belongs to the large clostridial cytotoxin family (Hofmann et al., 1995) . This family comprises glycosyltransferase by modifying small GTP-binding proteins, such as Rho and Ras, which inhibit signal pathways, thereby causing cytoskeletal disintegration (Oksche et al., 1992) , which in turn causes cell death. Alpha toxin has a tripartite structure in which the enzymatic activity is related to a 551-amino acid on the N-terminal, known as the catalytic domain (Busch et al., 2000) . The C-terminal of the toxin is the receptor-binding domain, and the hydrophobic domain in the central region is required for the translocation of the toxin into cytosol (von Eichel-Streiber et al., 1996) .
Vaccination is an effective means for the control of this disease. Whole-cell and toxoid vaccines are available, yet they have drawbacks such as incomplete inactivation and possible side effects. The use of recombinant DNA technology could result in antigens with high purity and safety (Fox and Klass, 1989) . Protective antibodies against this recombinant antigen could react to the whole antigen and effective vaccines, producing the need to identify B-cell epitopes (Atassi et al., 2012) . Therefore, epitope prediction is useful for the production of subunit and synthetic peptide vaccines and antibodies or antisera for competition assays.
Identification of B-cell epitope locations has been carried out with both experimental and computational methods. In some experimental approaches, overlapping peptide was synthesized and bound to the antibody against the whole antigen (Atassi et al., 2011) . Experimental techniques are time-consuming and expensive; furthermore, in the case of large proteins, it is laborious to carry out epitope mapping. Therefore, several prediction tools have been developed for identifying appropriate parts of protein as epitopes (Irving et al., 2001 ). This prediction is based on using computational methods and resources to extract immunological information and is known as immunoinformatics (Tomar and De, 2014) .
In this study, we designed a strategy to produce highly antigenic regions based on immunoinformatics methods in the recognized epitopic region, according to continuous, discontinuous, and T-cell epitopes. Production of antibodies was elicited by the immunization of mice with the recombinant protein. The ELISA test was used to evaluate the cross-reaction of antirecombinant protein with native toxin.
Materials and methods

Protein sequence analysis
The nucleotide sequence of the alpha toxin of Clostridium novyi was retrieved from the NCBI database (gi|728537|emb|Z48636.1|). The protein sequence and reading frame of alpha toxin were then predicted with ExPASy and CLC Main Workbench 6, and a translation frame was identified.
Prediction of protein secondary structure
The secondary structure (α-helix and β-sheet) of alpha toxin was predicted with CLC Main Workbench 6, after which the protein sequence was divided into 13 fragments (regions) with overlaps in order to aim for antigenicity and cloning in the future. Each fragment was designed to retain beta sheet and alpha helix structures.
B-cell and T-cell epitope identification
The IEDB and Bcepred servers were utilized to predict linear B cell epitopes. MHC class II epitopes were analyzed with the IEDB server.
Antigenic sites were determined by using the IEDB server and the Kolaskar and Tongaonkar antigenicity method. This program uses experimental antigenic determinant data and the physicochemical properties of amino acid residues (Kolaskar and Tongaonkar, 1990) . The Bcepred server was used to predict the linear B-cell epitope based on physicochemical properties (hydrophilicity, flexibility/mobility, accessibility, polarity, exposed surface, and turns) (Saha and Raghava, 2004) . The IEDB server predicts MHC class II epitopes by using a consensus approach that combines NN-align, SMMalign, and combinatorial library methods (Wang et al., 2008) . Since BALB/C mice were subjected to experimental analysis, an H2-IAd allele with more frequency in BALB/C was selected for the analysis (Ru, 2012) .
Homology modeling and quality evaluation
Homology modeling of the alpha toxin was carried out with I-TASSER. This server generates 3D models based on multiple threading alignments. In I-TASSER, the C-score was used to determine the accuracy of the models, after which the model with the highest C-score was used for further analysis (Roy et al., 2010) . Since the I-TASSER server only accepts sequences with <1500 residues, a region between 687 and 2178 amino acids was used for prediction (1500 residues). Swiss-Pdb Viewer 4.10 was used for energy-minimizing the best model (http://www. expasy.org/spdbv/) and, subsequently, Ramachandran plot analysis was carried out with RAMEPAGE (Lovell et al., 2003) .
Identification of conformational epitope
The Discotope 2.0 server was used for identifying discontinuous epitopes by using a 3D structure. The predicted epitope is based on surface accessibility and the epitope propensity amino acid score (Kringelum et al., 2012) . Epitopes in each fragment (region) were analyzed, and the fragment with the highest antigenicity was selected. 2.6. Analyzing the primary structure, restriction enzyme sites, and primer design An antigenic region, selected on the basis of immunoinformatic studies, was chosen for cloning and recombinant protein production. To characterize and purify the recombinant protein, analysis of the primary structure of the fragment with the Bioinformatics Server was helpful. ProtParam is a tool that computes the physical and chemical parameters of protein such as molecular weight, theoretical pI, and amino acid composition (http://web.expasy.org/protparam/) (Gasteiger et al., 2005) . NEBcutter 2.0 was used for the identification of restriction enzyme sites in the fragment (http://nc2.neb. com/NEBcutter2/). The primer sequence position was selected and designed with PrimerPremier 5: forward 5'-AAT GGA GAG CTT CAT TAC AAA AAT, reverse 5'-TTC TTC CCA ATT TCC ATT TAT ATT.
DNA extraction and PCR amplification of the antigenic fragment C. novyi was obtained from the Razi Vaccine and Serum
Research Institute, Mashhad, Iran. Clostridium novyi was grown in 1 L of medium, based on the medium described by Guan et al. (2011) . Genomic DNA of Clostridium novyi was extracted with the phenol-chloroform method (Cheng and Jiang, 2006) . PCR was carried out using Taq DNA polymerase. An antigenic fragment was amplified separately in a 40-µL volume. The annealing temperature for the antigenic fragment was 56 °C, and 30 cycles were repeated. All PCR steps had a duration of 40 s, except for an additional extension time of 10 min at 72 °C. Antigenic fragment (570 bp) amplicons were obtained and purified from the agarose gel (Sambrook et al., 2001 ).
Molecular cloning and sequencing of the antigenic fragment
The purified fragments were ligated in TA cloning vector pTZ57R/T. After transforming in DH5α E. coli, the desired plasmid construction was confirmed by PCR and extracted by the alkaline method (Sambrook et al., 2001 ). The recombinant plasmids and the pET-21a(+) vector were digested by SalI-EcoRI enzymes. The fragments were inserted into the pET-21a(+) vector and transformed into E.coli BL21 Codon plus. The positive clones were selected by blue-white screening (containing 100 µg mL -1 ampicillin, 40 µg mL -1 X-gal, and 40 µg mL -1 IPTG) and PCR testing and were sequenced for verification by Macrogen Company (Seoul, Korea).
Recombinant protein expression
The positive clone construct pET21a-ATF12 was cultured in LB broth containing 100 µg mL -1 ampicillin and was incubated at 37 °C and 200 rpm. After 16 h, it was transferred to LB medium (1 L) containing ampicillin and was incubated at 37 °C and 200 rpm. At an optical density of around 0.5 at 600 nm absorption, the culture was induced by adding 1 mM IPTG and this was continued for the next 4 h. 2.10. Cell lysate and partial purification of recombinant protein The cells were harvested by centrifugation at 5000 rpm for 15 min. Cell lysis was performed according to the method of Sarma et al. (2000) . Cell lysate was precipitated by 40% ammonium sulfate and partially purified by gel filtration (G50 Sephadex) chromatography. The recombinant protein activity was checked by ELISA and precipitated by 40% ammonium sulfate for further use in experiments. 2.11. Sandwich ELISA for determination of the recombinant protein ELISA testing was used to evaluate the amount of recombinant protein. A polyvinyl chloride 96-well plate (SPL strips immunoplates) was coated with 100 µL of 1 µg/mL antialpha toxin solution (antialpha toxin was prepared in the Razi Vaccine and Serum Research Institute, developed in rabbit). The assay was performed as described by McGregor et al. (1994) . 2.12. SDS-PAGE and western blotting SDS-PAGE were performed according to Laemmli (1970) . The recombinant protein cell lysate and purified recombinant protein were separated on 12.5% SDS-PAGE gel. Silver staining of the gel was used to detect protein.
Gel was blotted onto a nitrocellulose membrane and nonspecific binding was blocked with PBS (1.5%) for 1 h at 37 °C. The membrane was incubated with anti-His Tag HRP-conjugated antibody (1/2000) for 1 h at 37 °C. The membrane was washed three times in PBS-T (0.05% Tween-20) and three times in PBS, and then DAB substrate was used for detection.
Immunization
Three BALB/C mouse groups were separately immunized against 200 µg of recombinant protein, whole alpha toxin (formaldehyde-inactivated), and PBS as negative control. Chitosan was used as an adjuvant (de Paz et al., 2011) . Each group consisted of 3 mice that were injected weekly for 3 weeks. Bleeding of mice was carried out 7 days after the last injection. The sera were separated by centrifugation, and each group was mixed and stored at -20 °C until further analysis.
Characterization of mouse antibodies by crosscheck
A dot-blot test was prepared on nitrocellulose membrane to detect anti-pNTF12 in mouse serum. This test was performed according to Towbin and Gordon (1984) . BL21 lysate and PBS were used as negative controls in the test, and the membrane was purchased from Amersham Company (Little Chalfont, UK). Cross-reactions between the antirecombinant protein, antialpha toxin, and anti-PBS (all were diluted to 1:100) and 1 µg/mL solutions of native alpha toxin and the recombinant protein were carried out by ELISA test. This test was performed to measure serum responses to recombinant protein and native antigen.
Results
The secondary structure prediction of the alpha toxin with CLC Main Workbench 6 showed that the C-terminal region of the protein has more β-sheet structures than the N-terminal. As shown in Figure 1 , the protein sequence was divided into 13 fragments (NTF1-NTF13) with overlapping sequences.
The second part of the protein showed higher antigenicity than the first. The outcome of the two servers (IEDB and Bcepred) showed that fragments in the middle (NTF7, NTF8, NTF11, NTF12, and NTF13) and the C-terminal of the toxin were found to be antigenic in linear B-cell epitopes.
The IEDB outcome of T-cell epitopes revealed those residues in 3-17 (ITREQLMKIASIPLK), 
965-979 (LNSAMLMQLLIDYKP)
, and 983-997 (ILTNMNTSLKVQAYA), which are in NTF1 and NTF7, respectively. These fragments have high potential for binding to MHCII.
The overall analyses of the secondary structure, antigenicity plot of the B-cell epitope, and T-cell epitope results showed that the C-terminal region of the protein (+1000 aa) is more antigenic because the beta-sheet strand is more antigenic (Ingale, 2010) .
The 3D structure of the whole alpha toxin protein is not available in PDB; therefore, the I-TASSER server was used for prediction. The I-TASSER input sequence has restrictions (<1500) and, according to the results of the linear B-cell and T-cell epitopes analysis that showed the N-terminal of alpha toxin (687 residues in the beginning), it is less epitopic than the C-terminal of the toxin. Therefore, the N-terminal was omitted in further analysis. Residues between 687 and 2178 were selected for homology modeling. The model with the highest C-score was subjected to energy-minimizing with SwissPdb Viewer and Ramachandran plot analysis in order to validate the geometrical structure as a native-like protein.
As shown in Figure 2 , the alpha toxin model has 90.8% of amino acid residues in favored regions, 6.6% in allowed regions, and 2.6% in outlier regions. Therefore, the 3D structure of alpha toxin was confirmed and visualized with PyMOL ( Figure 3) .
The conformational epitope was predicted with Discotope 2.0 (Figure 4) . Results from Discotope identified 126 residues as epitopes of 1500 total residues with 62 epitopes located in NTF12 (Table) . Thus, NTF12 showed high antigenicity with the B-cell epitope prediction tools (continuous and discontinuous). Consequently, this region was chosen for further experimental evaluation using different proteomic techniques.
The primer sequences were designed for the amplification of NTF12. The primary structure shows that pNTF12 (the recombinant protein of NTF12) has a molecular weight of 22.5 kDa. A bioinformatics analysis of restriction enzyme sites shows the absence of SalI and EcoRI restriction sites in the fragment. Therefore, these restriction enzymes could be used to transform the NTF12 fragment from the pTZ vector and for subcloning into the pET-21a (+) expression vector.
PCR amplification of NTF12 resulted in a PCR product of 570 bp. The pET21a-NTF12 constructs were verified by PCR test and confirmed by DNA sequencing (data not shown).
Expression and antigenicity of pNTF12 were evaluated by ELISA testing (data not shown). It was observed that the antialpha toxin reacted with pNTF12, and it is hence suggested that the NTF12 region, as immunoinformatic analyses have shown, is an immunodominant region that reacts with antialpha toxin. After gel filtration chromatography, the partially purified pNTF12 was used for further analysis. The presence and purification of pNTF12 was also detected on polyacrylamide gel and western blotting analysis ( Figure 5 ). Dot-blotting results indicated that anti-pNTF12 could react to both pNTF12 and native alpha toxin (Figure 6 ). With immunological cross-reactivity, it was revealed that anti-pNTF12 could react to alpha toxin, which is 2.35-fold more reactive to alpha toxin than native antialpha toxin (Figure 7) . According to the experimental analysis, NTF12 predicted by immunoinformatics methods has immunodominant epitopes and therefore shows high antigenicity.
Discussion
Clostridium novyi is a spore-forming bacterium with a lethal toxin called alpha toxin, which causes gas gangrene in humans and animals. Alpha toxin causes edema that could lead to necrotic infections (Busch et al., 2000; McGuigan et al., 2002) . 1784 -1974 1832 , 1834 -1837 , 1839 -1841 , 1843 -1844 , 1869 , 1871 , 1875 , 1881 -1885 , 1887 -1891 , 1901 -1911 , 1924 -1930 42 NTF12 & 13 (overlap region) 1952 -1974 1943 -1956 ,1958 15 NTF13 1952 -2178 1975 -1977 , 1979 , 1981 , 2039 , 2047 , 2061 -2071 , 2101 , 2102 , 2130 Total epitopes 126
In our study, the second section of alpha toxin (residues >1000) has more antigenicity due to the beta sheet and coil structures. A B-linear antigenicity report shows that NTF7, NTF8, NTF11, NTF12, and NTF13 contain more antigenic determinants. NTF12 (1800-1958 amino acid residues) in conformational epitope analysis was introduced as a highly antigenic fragment. It was shown that >90% of B-cell epitopes are discontinuous (Barlow et al., 1986) . NTF1 and NTF7 in the amino terminal and central sections of the toxin were shown to be suitable binders to MHCII. It is suggested that the highest antigenicity of the terminal segment of the toxin is in its receptor binding activity, which is located on the protein surface and has high mobility. . Dot-blot test using anti-pNTF12 against pNTF12 and native alpha toxin. BL21 lysate and PBS were used as negative controls.
An analysis of the secondary structure of the protein showed that antigenic determinants are often found in loop-like structures on the surface of a molecule (Modrow et al., 1987) . Other studies showed that beta sheet regions have a higher immunity response compared to the helical regions (Ingale, 2010) .
An overall immunoinformatic analysis revealed that NTF12 is common in linear and conformational epitope analysis, making it a suitable candidate for inducing immunity. An advantage of NTF12 is that it is nontoxic due to the absence of a catalytic domain (N-terminal).
Based on our immunoinformatics analyses, NTF12 was chosen for production in E. coli cells, since it showed immunogenic potential. Immunological tests showed that pNTF12 was strongly recognized by antialpha toxin antibodies; therefore, it is suggested that this region has high antigenicity. Anti-NTF12 produced in mice recognized the alpha toxin and also had significantly higher reactivity to the native toxin than antialpha toxin. Thus, it seems that the NTF12 region could be used as an appropriate immunogen. We propose that the 3D structure and epitopes of the pNTF12 of alpha toxin is retained, preserving its native form. This is similar to the findings reported by Atassi et al. (2012) , who showed that an antibody prepared by immunization with surfacestimulation peptide had a high level of cross-reaction with native protein.
The production of traditional clostridial vaccines is an expensive, laborious, and hazardous process, because of necessary toxin inactivation and purification stages (Haesebrouck et al., 2004; Nijland et al., 2007) . Alpha toxin is a large protein with 2178 amino acids. Since a small fragment of an antigen can induce an immune response against the whole antigen, cloning and production of the regions with high antigenicity has opened new possibilities for immunity against lethal toxins. This study indicates various bioinformatics tools to determine potential antigenic regions (B-cell and T-cell epitopes) in alpha toxin, with the aim of producing this region in heterologous systems and immunization. Overall, our bioinformatics analysis has shown that the carboxyl terminal of the toxin as a highly antigenic region has a high probability for humoral immune response (B-cell epitope). In addition, for vaccine development, NTF1 or NTF7 could be used as a T-cell epitope. pNTF12 retains proper folding, which is essential for conformational epitopes due to the antibodies generated after mouse immunization with recombinant protein that is able to recognize the native alpha toxin. Furthermore, pNTF12 displays no toxicity after the immunization of mice. This evidence indicates that in silico analysis of antigenic regions, followed by in vitro and in vivo experiments, could be an effective strategy for considering a proper candidate for vaccine development. This strategy can be used for designing peptide vaccines and diagnostic tests. 
